A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib

doi:10.1016/j.cllc.2020.07.007

	A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib
	Chen, Kaiyan 2,3,4; Zhang, Fanrong 1,2; Pan, Guoqiang 2,3,4,5; Sheng, Jiamin 2,3,4,5; Ye, Junyi 6; Xu, Yanjun 2,3,4; Yu, Xiaoqing 2,3,4; Huang, Zhiyu 2,3,4; Fan, Yun 2,3,4
刊名	CLINICAL LUNG CANCER
	2021
卷号	22
关键词	Crizotinib MET Non-small-cell lung cancer RET Resistance
ISSN号	1525-7304
DOI	10.1016/j.cllc.2020.07.007
通讯作者	Fan, Yun(fanyun@zjcc.org.cn)
资助项目	Zhejiang Public Welfare Technology Research Program[LGF18H160017]
WOS关键词	CELL LUNG-CANCER ; ACQUIRED-RESISTANCE ; OPEN-LABEL ; CARCINOMAS ; PHASE-2
WOS研究方向	Oncology
语种	英语
出版者	CIG MEDIA GROUP, LP
WOS记录号	WOS:000608186600002
资助机构	Zhejiang Public Welfare Technology Research Program
内容类型	期刊论文
源URL	[http://ir.hfcas.ac.cn:8080/handle/334002/119772]
专题	中国科学院合肥物质科学研究院
通讯作者	Fan, Yun
作者单位	1.Zhejiang Canc Hosp, Dept Breast Surg, Hangzhou, Peoples R China 2.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 3.Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Peoples R China 4.Zhejiang Canc Hosp, Dept Thorac Med Oncol, Hangzhou, Peoples R China 5.Wenzhou Med Univ, Clin Med Coll 1, Dept Oncol, Wenzhou, Peoples R China 6.Bioinformat Dept, Burning Rock Biotech, Guangzhou, Peoples R China
推荐引用方式 GB/T 7714	Chen, Kaiyan,Zhang, Fanrong,Pan, Guoqiang,et al. A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib[J]. CLINICAL LUNG CANCER,2021,22.
APA	Chen, Kaiyan.,Zhang, Fanrong.,Pan, Guoqiang.,Sheng, Jiamin.,Ye, Junyi.,...&Fan, Yun.(2021).A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib.CLINICAL LUNG CANCER,22.
MLA	Chen, Kaiyan,et al."A Case of Resistance to Selective RET-TKI Therapy With Pleural-Genotyped MET Amplification and Response to Crizotinib".CLINICAL LUNG CANCER 22(2021).